One day - One Company

Email This Page

Lanxess in brief

Energizing Chemistry

Lanxess AG (Lanxess) is a young company founded in 2005 with 150 years of history in the chemical industry as the result of Bayer strategic spin off of plastics and synthetic rubber assets.

Still home-based with Bayer in Leverkusen, Germany, will relocate headquarters next door in Cologne,  in 2013.

Lanxess is covering 31 countries with 16,900 employees.

Operating 49 production sites through 13 business units, Lanxess was created to focus on three segments:

 – Performance Polymers such as plastics and elastomers based on butyl-rubber, performances butadiene rubbers, high performances materials and technical rubber

 – Advanced intermediates including bulk and fine chemicals, and advanced industrial intermediates  

 – Performances Chemicals covering functional chemicals, ions exchange resins, synthetic leather, material protection fibers and compounds, inorganic pigments. Rhein Chemie und Rubber Chemicals also belongs to the Performances Chemicals segment. 

In separating these activities, Lanxess can benefit from its years of expertise accumulated within Bayer, and in the same time adjust its structure to grow faster with shorter circuits of decisions.

Lanxess Key Figures

 – 2011 Revenues: $11,23 billion

 – 2010 Revenues: $9,11 billion

 – 2009 Revenues: $6,47 billion

 – 2011 Earnings: $0,647 billion

 – 2010 Earnings: $0,485 billion

 – 2009 Earnings: $0,051 billion

 – 2011 Capital Expenditure: $0,896 billion

 – 2010 Capital Expenditure: $0,677 billion

 – 2009 Capital Expenditure: $0,352 billion

Lanxess Projects and Business Highlights

The results of Lanxess first years of existence as independent company seems to confirm the validity of the decision to create a separate company to focus on the three segments performances polymers, Advanced intermediates, and performances chemicals.

In a context, where the global demand for high performances plastics increases constantly, Lanxess will continue to develop versatile polymers materials for the car industry, the electronics applications, agriculture and white goods.

The other sector to go for growth is associated to the synthetic rubber where Lanxess is building its market leadership in the green tires to save energy and high resistance rubbers for transmissions and electrical cars applications.

In that respect the tire labeling enforced in Europe in 2012 to differentiate the energy efficient tires from the bulk will contribute to boost Lanxess synthetic rubber offering.

With Performances Chemicals Lanxess, develops iron oxide pigments for the electrical cars lithium-ion batteries.

Since China is emerging as the largest market for the car industry, Lanxess is planning to build the world largest ethylene propylene diene monomer (EPDM) plant at Changzhou, in the Jiangsu Province, China.

In this greenfield project, Lanxess will use its proprietary Advanced Catalysis Elastomers (ACE) technology that speeds up the manufacturing process, reduces the consumption of catalysis, thus the consumption of energy.

Lanxess selected Foster Wheeler for the front end engineering and design (FEED and for the engineering, procurement and construction (EPC) management.

As Asia remains the most attractive market for synthetic rubber, Lanxess is also working on new Neodynium Polybutadiene rubber (Nd-PBR) plant in Jurong Island, Singapore.

With $200 million capital expenditure, Lanxess is expecting the first production in 2015.

After a couple of years to settle Lanxess as a separate company, Lanxess goes global with a focus on fast growing markets and high-tech chemical specialties ahead of competition.

With greenfield projects and expansion in the north and south of Asia, Lanxess is positioning to seize all opportunities.

For more information and data about oil and gas and petrochemical projects go to Project Smart Explorer

Leave a Reply

short term loans . In this section we give only a brief summary recommendation for admission of Levitra Sale. Full information can be found in the instructions for receiving medications with vardenafil.